This inventor holds 1 USPTO granted patent. Top assignee: National Defense Medical Center. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Chao-Wen Cheng: Innovator in Kidney Disease Diagnosis
Introduction
Chao-Wen Cheng is a notable inventor based in Magong, Taiwan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of kidney diseases. His innovative approach utilizes specific biomarkers to enhance the accuracy of kidney disease diagnosis.
Latest Patents
Cheng holds a patent titled "Method for diagnosing kidney disease comprising detecting the level of annexin A2." This invention provides biomarkers for detecting kidney disease, which include the oligonucleotide sequence, complementary sequence or derivatives, amino acid sequence or derivatives, fragments, variants, and antibodies of annexin A2 or S100A6, or combinations thereof. Additionally, the invention offers an assay kit and a method for detecting kidney disease, particularly useful for conditions resulting from acute tubular necrosis.
Career Highlights
Chao-Wen Cheng is affiliated with the National Defense Medical Center, where he applies his expertise in medical research and innovation. His work has been instrumental in advancing diagnostic methods that can lead to better patient outcomes.
Collaborations
Cheng collaborates with talented individuals in his field, including Chen-Wen Yao and Ann Chen, who contribute to his research endeavors.
Conclusion
Chao-Wen Cheng's contributions to kidney disease diagnostics exemplify the impact of innovative thinking in medicine. His patent and ongoing work continue to pave the way for advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile